Moscow : Health officials in Russia has authorised the one-shot Sputnik Light version of its coronavirus vaccine for use, the Russian Direct Investment Fund (RDIF) announced today, a move that could help vaccine supplies go further in countries with high infection rates. The developers of the shot said, in a statement, that Sputnik Light “demonstrated 79.4% efficacy” compared to 91.6% for the two-shot Sputnik V.The single-dose Sputnik Light vaccine demonstrated 79.4% efficacy according to analysed data taken from 28 days after the injection was administered as part of Russia’s mass vaccination programme between 5 December 2020 and 15 April 2021,” the RDIF said in a statement.

Introducing a new member of the Sputnik family – a single dose Sputnik Light!

It’s a revolutionary 1-shot COVID-19 vaccine with the 80% efficacy – higher than many 2-shot vaccines.

Sputnik Light will double vaccination rates and help to handle epidemic peaks ✌️ pic.twitter.com/BCybe8yYWU

— Sputnik V (@sputnikvaccine) May 6, 2021

Following 2 country authorizations today, Sputnik V is now approved in 64 countries with population of over 3.2 billion people ✌️ pic.twitter.com/UkF1f51Vbu

— Sputnik V (@sputnikvaccine) April 30, 2021